Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)

Recruiting

Abemaciclib & ETAbemaciclib Dose Escalation to Maintain Intensity (ADE-MI)

Sponsor:

University of Illinois at Chicago

Code:

NCT06169371

Conditions

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Abemaciclib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-13. This information was provided to ClinicalTrials.gov by University of Illinois at Chicago on 2025-03-27.